Who invested in Shinobi Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$68Mraised across 1 round since 2024, from 1 source

Latest round: Series A, $68MAug 2024
Investors: 3

See who backed them

The rounds

Aug 2024
Series A$68M
Source recorded

Founders and team

From Shinobi Therapeutics's own website: 3 on the team.

Shinobi TherapeuticsCEO of Shinobi Therapeutics
Kristi LanierCFO
Robert WeisskoffBoard of Directors

Everyone who backed them

Mitsubishi UFJ CapitalVC firm1round

JIC Venture Growth InvestmentsVC firm1round

EQT Life SciencesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Shinobi Therapeutics

Who invested in Shinobi Therapeutics?

Shinobi Therapeutics's investors include Mitsubishi UFJ Capital, JIC Venture Growth Investments and EQT Life Sciences.

How much has Shinobi Therapeutics raised?

Shinobi Therapeutics has raised $68M across 1 round since 2024.

When did Shinobi Therapeutics last raise?

Shinobi Therapeutics's most recent round was a Series A of $68M in Aug 2024.

What was Shinobi Therapeutics's biggest round?

Its most recent round, $68M in Aug 2024, is also its largest on record.

Who backed Shinobi Therapeutics first?

Shinobi Therapeutics's first round on record, in Aug 2024, was backed by Mitsubishi UFJ Capital, JIC Venture Growth Investments and EQT Life Sciences.